Table 2.
Retinal Thickness Analysis by Diabetic Status: Summary Data of Stratus OCT™ Parameters for Diabetic and Nondiabetic Patients
OCT Parameter | Diabetic | Nondiabetic | P-Valuea |
---|---|---|---|
Centerpoint Foveal Thickness | 157.8 ± 3.2 µm | 156.9 ± 3.2 µm | 0.86 |
Mean Foveal Thickness | 191.6 ± 2.7 µm | 194.5 ± 2.7 µm | 0.49 |
Temporal Inner Macular | 255.6 ± 1.9 µm | 259.7 ± 2.4 µm | 0.16 |
Superior Inner Macula | 272.2 ± 2.1 µm | 274.9 ± 2.1 µm | 0.39 |
Nasal Inner Macula | 269.3 ± 2.0 µm | 273.3 ± 2.0 µm | 0.18 |
Inferior Inner Macula | 266.8 ± 2.0 µm | 270.5 ± 2.5 µm | 0.22 |
Temporal Outer Macula | 221.0 ± 1.8 µm | 222.7 ± 1.8 µm | 0.54 |
Superior Outer Macula | 240.7 ± 2.1 µm | 242.3 ± 2.8 µm | 0.64 |
Nasal Outer Macula | 257.6 ± 2.2 µm | 257.0 ± 2.2 µm | 0.85 |
Inferior Outer Macula | 230.3 ± 1.9 µm | 229.3 ± 2.6 µm | 0.75 |
Total Macular Volume | 6.91 ± 0.06 mm3 | 6.81 ± 0.11 mm3 | 0.50 |
Generalized estimating equation (GEE), which adjusts for the correlation between eyes, was employed in the analyses. The Wald Chi-Square P-value is reported and means are given as least square mean ± se. All models are adjusted for race, gender, and age group (categorized by decades: 20’s, 30’s, 40’s,50’s, and 60+).